• Saturday, August 22, 2026
    • 23.7 °C NP

Experimental therapy gantenerumab fails to slow or improve Alzheimer's memory loss in clinical trials

  • 0
  • 3 years ago
Image

An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer's or those who were in the early phases of the disease, the manufacturer said Monday.

Comments

Add a comment

Subscribe To Our Newsletter

Want to be notified when we launch a new template or an udpate. Just sign up and we'll send you a notification by email.